Unknown

Dataset Information

0

Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.

ABSTRACT:

SUBMITTER: Bolen CR 

PROVIDER: S-EPMC8120142 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.
| S-EPMC6034646 | biostudies-literature
Unknown An Immune-Clinical Prognostic Index (ICPI) for Patients With <i>De Novo</i> Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy.
| S-EPMC8316046 | biostudies-literature
Unknown A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era.
| S-EPMC7062756 | biostudies-literature
Unknown De novo generation of hit-like molecules from gene expression signatures using artificial intelligence.
| S-EPMC6941972 | biostudies-literature
Unknown Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
| S-EPMC4855088 | biostudies-other
Unknown Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
| S-EPMC4014836 | biostudies-literature
Unknown Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
| S-EPMC9316992 | biostudies-literature
Unknown Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
| S-EPMC4823044 | biostudies-literature
Unknown Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
| S-EPMC1890834 | biostudies-literature
Unknown FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
| S-EPMC5757687 | biostudies-literature